PURE BIOSCIENCE, INC. Quarterly Operating Margin in % from Q2 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Pure Bioscience, Inc. quarterly/annual Operating Margin history and growth rate from Q2 2021 to Q2 2024.
  • Pure Bioscience, Inc. Operating Margin for the quarter ending July 31, 2024 was -163 %, a 22.5% increase year-over-year.
  • Pure Bioscience, Inc. annual Operating Margin for 2024 was -163 %, a 22.5% increase from 2023.
  • Pure Bioscience, Inc. annual Operating Margin for 2023 was -211 %, a 2.6% decline from 2022.
  • Pure Bioscience, Inc. annual Operating Margin for 2022 was -205 %, a 229% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -163 +47.5 +22.5% May 1, 2024 Jul 31, 2024
Q1 2024 -169 +79.4 +32% Feb 1, 2024 Apr 30, 2024
Q4 2023 -174 +54.4 +23.8% Nov 1, 2023 Jan 31, 2024
Q3 2023 -173 +46.7 +21.3% Aug 1, 2023 Oct 31, 2023
Q2 2023 -211 -5.34 -2.6% May 1, 2023 Jul 31, 2023
Q1 2023 -248 -106 -74.4% Feb 1, 2023 Apr 30, 2023
Q4 2022 -229 -87.9 -62.4% Nov 1, 2022 Jan 31, 2023
Q3 2022 -220 -114 -108% Aug 1, 2022 Oct 31, 2022
Q2 2022 -205 -143 -229% May 1, 2022 Jul 31, 2022
Q1 2022 -142 Feb 1, 2022 Apr 30, 2022
Q4 2021 -141 Nov 1, 2021 Jan 31, 2022
Q3 2021 -105 Aug 1, 2021 Oct 31, 2021
Q2 2021 -62.5 May 1, 2021 Jul 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.